TechNavio today launched its report, Global Tissue Engineering and Cell Therapy Market 2011-2015, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The Global Tissue Engineering and Cell Therapy market is witnessing an increase in mergers and acquisitions among the global and regional vendors. There has been a significant increase in the acquisition of small and medium-sized companies by the leading tissue engineering and regenerative medicine developers.”
According to the report, one of the major factors driving the Global Tissue Engineering and Cell Therapy market is the significant developments in RandD. Most of the applications in tissue engineering are at their nascent stage. Therefore, reputable vendors are investing more in RandD to evolve with more patents in the Global Tissue Engineering and Cell Therapy market.
Further, the report reveals that one of the major challenges for this market is the stringent regulatory approval conditions applied to cell-based therapy products.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-tissue-engineering-and-cell-ther…
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Tissue Engineering and Cell Therapy Market 2011-2015
